| 000 | 01686 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517184206.0 | ||
| 264 | 0 | _c20190117 | |
| 008 | 201901s 0 0 eng d | ||
| 022 | _a1432-0738 | ||
| 024 | 7 |
_a10.1007/s00204-017-2108-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBloch-Shilderman, E | |
| 245 | 0 | 0 |
_aDetermining a threshold sub-acute dose leading to minimal physiological alterations following prolonged exposure to the nerve agent VX in rats. _h[electronic resource] |
| 260 |
_bArchives of toxicology _cFeb 2018 |
||
| 300 |
_a873-892 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aBody Temperature |
| 650 | 0 | 4 | _aBody Weight |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 |
_aCarrier Proteins _xmetabolism |
| 650 | 0 | 4 |
_aChemical Warfare Agents _xtoxicity |
| 650 | 0 | 4 |
_aCholinesterase Inhibitors _xtoxicity |
| 650 | 0 | 4 |
_aCholinesterases _xblood |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMotor Activity |
| 650 | 0 | 4 |
_aMuscles _xdrug effects |
| 650 | 0 | 4 |
_aNerve Agents _xtoxicity |
| 650 | 0 | 4 |
_aOrganothiophosphorus Compounds _xtoxicity |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptor, Muscarinic M2 _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, GABA-A _xmetabolism |
| 650 | 0 | 4 | _aToxicity Tests, Chronic |
| 700 | 1 | _aRabinovitz, I | |
| 700 | 1 | _aEgoz, I | |
| 700 | 1 | _aYacov, G | |
| 700 | 1 | _aAllon, N | |
| 700 | 1 | _aNili, U | |
| 773 | 0 |
_tArchives of toxicology _gvol. 92 _gno. 2 _gp. 873-892 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00204-017-2108-5 _zAvailable from publisher's website |
| 999 |
_c27778073 _d27778073 |
||